Search

Search Constraints

You searched for: Author/Creator Bundschuh, Ralph A.

Search Results

2. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma. (May 2018)

3. Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy. Issue 14 (21st July 2022)

4. Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases. Issue 10 (1st October 2016)

5. High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data. (10th March 2023)

6. Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4–Directed Molecular Imaging and Therapy. (22nd June 2023)

7. Lack of repeatability of radiomic features derived from PET scans: Results from a 18F‐DCFPyL test–retest cohort. Issue 6 (11th January 2023)

8. Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma. (July 2018)

9. Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases. (31st January 2020)